GRRMY (Gerresheimer AG) Total Inventories : $371 Mil (As of Nov. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Gerresheimer AG Total Inventories?

Gerresheimer AG's total inventories for the quarter that ended in Nov. 2024 was $371 Mil. Gerresheimer AG's average total inventories from the quarter that ended in Aug. 2024 to the quarter that ended in Nov. 2024 was $391 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Gerresheimer AG's Net-Net Working Capital per share for the quarter that ended in Nov. 2024 was $-12.88.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Gerresheimer AG's Days Inventory for the three months ended in Nov. 2024 was 86.72.

Inventory Turnover measures how fast the company turns over its inventory within a year. Gerresheimer AG's Inventory Turnover for the quarter that ended in Nov. 2024 was 1.05.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Gerresheimer AG's Inventory-to-Revenue for the quarter that ended in Nov. 2024 was 0.65.

Gerresheimer AG Total Inventories Historical Data

The historical data trend for Gerresheimer AG's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Total Inventories Chart

Gerresheimer AG Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Total Inventories

Get a 7-Day Free Trial

220.52

268.78

310.28

349.94

371.28

Gerresheimer AG Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Total Inventories	Get a 7-Day Free Trial															349.94	378.64	395.56	409.99	371.28

Gerresheimer AG Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Gerresheimer AG (OTCPK:GRRMY) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Gerresheimer AG's Net-Net Working Capital Per Share for the quarter that ended in Nov. 2024 is

	Net-Net Working Capital Per Share (Q: Nov. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(226.177	+	0.75 * 329.768	+	0.5 * 371.278	-	2409.791
-	0	-	29.277)	/	138.160
=	-12.88

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gerresheimer AG's Days Inventory for the three months ended in Nov. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Nov. 2024 )	/	Cost of Goods Sold (Q: Nov. 2024 )	*	Days in Period
	=	390.6355	/	411.033	*	365 / 4
	=	86.72

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Gerresheimer AG's Inventory Turnover for the quarter that ended in Nov. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Nov. 2024 )	/	Average Total Inventories (Q: Nov. 2024 )
	=	411.033	/	390.6355
	=	1.05

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gerresheimer AG's Inventory to Revenue for the quarter that ended in Nov. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Nov. 2024 )	/	Revenue (Q: Nov. 2024 )
	=	390.6355	/	603.899
	=	0.65

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Gerresheimer AG Total Inventories Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (OTCPK:GRRMY) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

GRRMF:USA GXId:UK 0NTI:UK GXI:Germany GXI:Austria

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.